Efficacy and influencing factors of allogeneic hematopoietic stem cell transplantation in treatment of 71 children with leukemia  

作　　者：Bing-Lei Zhang Jian Zhou Tian-Xi Lyu Rui-Rui Gui Ying-Ling Zu Feng-Kuan Yu Hui-Fang Zhao Zhen Li Juan Wang Yan-Li Zhang Wen-Lin Zhang Yue-Wen Fu Xu-Dong Wei Bai-Jun Fang Yu-Fu Li Ke-Shu Zhou Yong-Ping Song 

机构地区：[1]Department of Hematology,Tumor Hospital Affiliated to Zhengzhou University,Henan Cancer Hospital,Zhengzhou,Henan 450003,China

出　　处：《Chinese Medical Journal》2019年第7期860-864,共5页中华医学杂志（英文版）

摘　　要：To the Editor:Leukemia is a malignant proliferative disease that has become the most common malignancy in children,accounting for 40.5%of malignant cancers children.[1]Although chemotherapy can effectively treat children,some patients with high-risk and relapsed acute lymphoblastic leukemia(ALL)and acute myelocytic leukemia(AML)failed to achieve long-term relief.For these patients,allogeneic hematopoietic stem cell transplantation(allo-HSCT)is the best choice.However,many factors may impact the efficacy of allo-HSCT.We retrospectively analyzed the clinical data of 71 children with leukemia treated using allo-HSCT to observe the clinical efficacy and analyze the possible influencing factors.

关 键 词：ALLOGENEIC HEMATOPOIETIC stem cell TRANSPLANTATION LEUKEMIA MALIGNANT CANCERS children 

分 类 号：R[医药卫生]